23682254|t|Delirium associated with donepezil in a patient with Alzheimer's disease: a case report.
23682254|a|Donepezil, a member of the acetylcholinesterase inhibitor family, is approved for management of cognitive impairments as well as behavioral complications in patients with neurodegenerative Alzheimer's disease. Generally, donepezil is regarded as a safe medication in patients with Alzheimer's disease although there have been reports of several minor adverse events including gastrointestinal disturbances. Herein we describe a patient with Alzheimer's disease who demonstrated delirious behavior upon treatment with donepezil.
23682254	0	8	Delirium	Disease	MESH:D003693
23682254	25	34	donepezil	Chemical	MESH:D000077265
23682254	40	47	patient	Species	9606
23682254	53	72	Alzheimer's disease	Disease	MESH:D000544
23682254	89	98	Donepezil	Chemical	MESH:D000077265
23682254	185	206	cognitive impairments	Disease	MESH:D003072
23682254	246	254	patients	Species	9606
23682254	278	297	Alzheimer's disease	Disease	MESH:D000544
23682254	310	319	donepezil	Chemical	MESH:D000077265
23682254	356	364	patients	Species	9606
23682254	370	389	Alzheimer's disease	Disease	MESH:D000544
23682254	465	494	gastrointestinal disturbances	Disease	MESH:D005767
23682254	517	524	patient	Species	9606
23682254	530	549	Alzheimer's disease	Disease	MESH:D000544
23682254	606	615	donepezil	Chemical	MESH:D000077265
23682254	Positive_Correlation	MESH:D000077265	MESH:D005767
23682254	Positive_Correlation	MESH:D000077265	MESH:D003693
23682254	Negative_Correlation	MESH:D000077265	MESH:D000544
23682254	Negative_Correlation	MESH:D000077265	MESH:D003072

